Japan Animal Referral Medical Center Co..,Ltd.
6039・Growth Market・Services
Animal Medical Care Business (Single Segment)
Japan's only private-sector group specializing in secondary veterinary care for animals. Continues to achieve high growth by capturing demand for advanced pet medical care.
| Period | Current | Previous | Change |
|---|---|---|---|
| Net Sales | ¥6,192 million | ¥5,277 million | ↑ |
| Operating Profit | ¥1,150 million | ¥720 million | ↑ |
| Ordinary Profit | ¥1,142 million | ¥720 million | ↑ |
| Profit Attributable to Owners of Parent | ¥833 million | ¥520 million | ↑ |
| Operating Profit Margin | 18.6% | 13.7% | ↑ |
| Number of Initial Consultations (Full Year) | 10,953 cases | up 9.2% year on year | ↑ |
| Total Number of Consultations (Full Year) | 37,985 cases | up 8.6% year on year | ↑ |
| Number of Surgeries (Full Year) | 3,404 cases | up 11.0% year on year | ↑ |
| Number of Affiliated Hospitals | 4,779 facilities | 4,647 facilities (end of prior period) | ↑ |
| Total Assets | ¥11,313 million | ¥8,753 million | ↑ |
| Net Assets | ¥4,881 million | ¥4,148 million | ↑ |
| Equity Ratio | 43.1% | 47.4% | ↓ |
| Earnings Per Share | ¥64.48 | ¥40.22 | ↑ |
Business Details
Operates three businesses: Secondary Veterinary Care Services provided upon referral from primary care facilities (four locations: Kawasaki head hospital, Tokyo, Nagoya, and Osaka), MRI/CT Diagnostic Imaging Services (CAMIC), and Veterinary Medical & Health Management Equipment (oxygen cages, etc.) Rental/Sales (Telcom). Demand for advanced animal medical care has been expanding year by year against the backdrop of pets being treated as family members and the aging of pet populations, and the company differentiates itself through a complete referral system and a team of specialist veterinarians. The number of affiliated hospitals reached 4,779 facilities (as of end-March 2026), forming a robust network with primary care facilities nationwide.
Recent Overview
In FY2026 (ending March 2026), net sales and each profit metric renewed record highs for the second consecutive period, with operating profit up 59.5% year on year.
In FY2026 (ending March 2026), net sales reached ¥6,192 million (up 17.3% year on year), operating profit reached ¥1,150 million (up 59.5% year on year), and net profit reached ¥833 million (up 60.0% year on year), renewing record highs across all metrics. Both the number of consultations and unit prices expanded, and the number of affiliated hospitals reached 4,779 facilities, an increase of 132 facilities from the end of the prior period. On the other hand, due to capital expenditures such as land acquisition (expenditure on acquisition of tangible fixed assets of ¥2,349 million), the company newly raised ¥2,038 million in short-term borrowings, and the equity ratio declined from 47.4% to 43.1%. A 1-for-5 stock split was implemented in December 2025. For FY2027 (ending March 2027), the company forecasts net sales of ¥6,600 million (up 6.6% year on year) and operating profit of ¥1,270 million (up 10.4% year on year).
Key Products
Growth Drivers
- Structural expansion of demand for advanced animal medical care driven by pets being treated as family members and the aging of pet populations
- Expansion of consultation capacity through review of treatment flows and strengthened recruitment and training of veterinarians
- Increase in unit consultation prices due to the June 2025 price revision (secondary care and diagnostic imaging) and the October 2025 price revision (rental and sales)
- Expansion of referral volume driven by continued increase in the number of affiliated hospitals (4,779 facilities, up 132 facilities from the end of the prior period)
- Integration of CRM within the group and strengthened mutual collaboration in sales and services
- Optimization of medical treatment operations and advanced utilization of data through introduction of next-generation electronic medical record systems
- Expansion of consultation capacity through human capital investment (strengthened recruitment of specialized personnel and improved compensation) and hospital expansion and new establishment
- New revenue opportunities through verification and service development of advanced technologies such as AI utilization and pet tech
Risks
- Continued situation where consultation demand consistently exceeds capacity, creating a risk of opportunity loss
- Risk of rising personnel acquisition costs due to intensifying competition for recruiting specialized veterinarians, veterinary nurses, and other staff
- Risk of delays in the development and introduction of next-generation electronic medical record systems
- Risk of delays in parts procurement and manufacturing of veterinary medical equipment and postponement of next-generation product release timing due to uncertainty surrounding the situation in the Middle East
- Financial burden associated with capital expenditures such as the renewal of the Nagoya hospital and new expansion into Fukuoka, Kyushu (including an increase in interest-bearing debt, including short-term borrowings of ¥2,038 million)
- Risk of increased interest payments due to rising interest rates (long-term borrowings balance of ¥2,476 million, short-term borrowings of ¥2,038 million)
- Information security risk (holding large volumes of patient medical records and imaging data)
- Impact on financial soundness associated with the decline in the equity ratio (from 47.4% to 43.1%)
Last updated: June 22, 2026